The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Predictors of treatment interruption/dose reduction of neoadjuvant chemotherapy for rectal cancer: A multicenter study.
Soundouss Raissouni
No relevant relationships to disclose
Dawn Elizabeth Armstrong
No relevant relationships to disclose
Julie A. Price Hiller
No relevant relationships to disclose
Jamison Mercer
No relevant relationships to disclose
Erin Diana Powell
No relevant relationships to disclose
Anthony MacLean
No relevant relationships to disclose
Maria Jiang
No relevant relationships to disclose
Corinne M. Doll
No relevant relationships to disclose
Rachel Anne Goodwin
No relevant relationships to disclose
Eugene Batuyong
No relevant relationships to disclose
Kevin Zhou
No relevant relationships to disclose
Jose Gerard Monzon
No relevant relationships to disclose
Patricia Tang
No relevant relationships to disclose
Daniel Yick Chin Heng
No relevant relationships to disclose
Winson Y. Cheung
No relevant relationships to disclose
Michael M. Vickers
No relevant relationships to disclose